Publicaciones (52) Publicaciones en las que ha participado algún/a investigador/a

2013

  1. A simple and efficient method for the production of human glycosylated glial cell line-derived neurotrophic factor using a Semliki Forest virus expression system

    International Journal of Pharmaceutics, Vol. 440, Núm. 1, pp. 19-26

  2. A synthetic peptide from transforming growth factor-β1 Type III receptor inhibits NADPH oxidase and prevents oxidative stress in the kidney of spontaneously hypertensive rats

    Antioxidants and Redox Signaling, Vol. 19, Núm. 14, pp. 1607-1618

  3. Aberrant DNA methylation profile of chronic and transformed classic Philadelphia-negative myeloproliferative neoplasms

    Haematologica, Vol. 98, Núm. 9, pp. 1414-1420

  4. Adipose tissue-derived mesenchymal stem cells: Isolation, expansion, and characterization

    Methods in Molecular Biology, Vol. 1036, pp. 47-61

  5. Age-related mitochondrial alterations without neuronal loss in the hippocampus of a transgenic model of Alzheimer's disease

    Current Alzheimer Research, Vol. 10, Núm. 4, pp. 390-405

  6. Alcohol consumption on pancreatic diseases

    World Journal of Gastroenterology, Vol. 19, Núm. 5, pp. 638-647

  7. Association of cardiotrophin-1 with left ventricular systolic properties in asymptomatic hypertensive patients

    Journal of Hypertension, Vol. 31, Núm. 3, pp. 587-594

  8. Biallelic losses of 13q do not confer a poorer outcome in chronic lymphocytic leukaemia: Analysis of 627 patients with isolated 13q deletion

    British Journal of Haematology, Vol. 163, Núm. 1, pp. 47-54

  9. Characterization and prognostic implication of 17 chromosome abnormalities in myelodysplastic syndrome

    Leukemia Research, Vol. 37, Núm. 7, pp. 769-776

  10. Chuck Close y los rostros perdidos

    Nuestro tiempo, Núm. 679, pp. 28-33

  11. Combined immunostimulatory monoclonal antibodies extend survival in an aggressive transgenic hepatocellular carcinoma mouse model

    Clinical Cancer Research, Vol. 19, Núm. 22, pp. 6151-6162

  12. Complement inhibition in cancer therapy

    Seminars in Immunology, Vol. 25, Núm. 1, pp. 54-64

  13. Decreased Nox4 levels in the myocardium of patients with aortic valve stenosis

    Clinical Science, Vol. 125, Núm. 6, pp. 291-300

  14. Downregulation of FOXP1 is required during germinal center B-cell function

    Blood, Vol. 121, Núm. 21, pp. 4311-4320

  15. Downregulation of specific miRNAs in hyperdiploid multiple myeloma mimics the oncogenic effect of IgH translocations occurring in the non-hyperdiploid subtype

    Leukemia, Vol. 27, Núm. 4, pp. 925-931

  16. Drug development in Parkinson's disease: From emerging molecules to innovative drug delivery systems

    Maturitas, Vol. 76, Núm. 3, pp. 272-278

  17. Edelfosine lipid nanosystems overcome drug resistance in leukemic cell lines

    Cancer Letters, Vol. 334, Núm. 2, pp. 302-310

  18. El misterio de la vida en un mecano

    Nuestro tiempo, Núm. 679, pp. 71-71

  19. Expression of SLC22A1 variants may affect the response of hepatocellular carcinoma and cholangiocarcinoma to sorafenib

    Hepatology, Vol. 58, Núm. 3, pp. 1065-1073

  20. Functional characterization of the promoter region of the human EVI1 gene in acute myeloid leukemia: RUNX1 and ELK1 directly regulate its transcription

    Oncogene, Vol. 32, Núm. 16, pp. 2069-2078